Testing effectiveness (Phase 2)Ended earlyNCT00916617What this trial is testingStudy Evaluating The Long-Term Safety And Efficacy Of Subcutaneous BapineuzumabWho this might be right forAlzheimer Disease Pfizer 62
Large-scale testing (Phase 3)WithdrawnNCT01211782What this trial is testingAC-1204 Long-term Efficacy Response Trial (ALERT Protocol)Who this might be right forAlzheimer's Disease Cerecin
Testing effectiveness (Phase 2)UnknownNCT01569516What this trial is testingStudy of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Changchun Huayang High-tech Co., Ltd 288
Early research (Phase 1)Study completedNCT01850238What this trial is testingSafety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's DiseaseWho this might be right forAlzheimer Disease Axon Neuroscience SE 30
Early research (Phase 1)Study completedNCT05667649What this trial is testingAutologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Regeneration Biomedical, Inc. 7
Early research (Phase 1)WithdrawnNCT03316898What this trial is testingA FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Allergan
Not applicableStudy completedNCT01796314What this trial is testingImpact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of LifeWho this might be right forAlzheimer Disease University Hospital, Toulouse 170
Large-scale testing (Phase 3)Study completedNCT00053599What this trial is testingCholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyWho this might be right forAlzheimer Disease National Institute on Aging (NIA) 400
Early research (Phase 1)Study completedNCT02434718What this trial is testingSingle and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Biogen 21
Testing effectiveness (Phase 2)Study completedNCT00566397What this trial is testingStudy Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 402
Large-scale testing (Phase 3)Ended earlyNCT01736579What this trial is testingLong-Term Study of IGIV, 10% in Alzheimer´s DiseaseWho this might be right forAlzheimer´s Disease Baxalta now part of Shire 6
Testing effectiveness (Phase 2)Study completedNCT02626572What this trial is testingEfficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive SymptomsWho this might be right forAlzheimer's Disease Institut de Recherches Internationales Servier 500
Large-scale testing (Phase 3)Temporarily pausedNCT04520412What this trial is testingSodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 2,046
Early research (Phase 1)Study completedNCT00736775What this trial is testingThe Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Genentech, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT01009255What this trial is testingStudy to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's DiseaseWho this might be right forAlzheimer's Disease GlaxoSmithKline 196
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07205601What this trial is testingStudy of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Regeneration Biomedical, Inc. 115
Not applicableStudy completedNCT04404153What this trial is testingNeurostimulation for Cognitive Enhancement in Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseDementia Albert Einstein College of Medicine 100
Early research (Phase 1)Study completedNCT02036645What this trial is testingSAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.Who this might be right forMild-Moderate Alzheimer's DiseaseHealthy Elderly AstraZeneca 77
Not applicableUnknownNCT03352739What this trial is testingFornix and NbM as Targets of Stimulation In Alzheimer's DiseaseWho this might be right forAlzheimer Disease Xuanwu Hospital, Beijing 30
Early research (Phase 1)Study completedNCT00988598What this trial is testingA Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 15